Join
Live feed
·
INSIDERFilingvia Quantisnow
Puma Biotechnology Inc logo

Director Moyes Jay M was granted 27,000 shares and sold $158,796 worth of shares (22,000 units at $7.22) as part of a pre-agreed trading plan, increasing direct ownership by 9% to 58,322 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PBYI (Puma Biotechnology Inc) and more on Quantisnow.

Director Moyes Jay M was granted 27,000 shares and sold $158,796 worth of shares (22,000 units at $7.22) as part of a pre-agreed trading plan, increasing direct ownership by 9% to 58,322 units (SEC Form 4) | Quantisnow